Navigation Links
Midwest life science stocks kept sizzling in Q2

Amazing what can happen in three short months! The major stock indices looked pretty lackluster at the end of the first quarter, but have picked up steam in the second quarter with the Dow Jones going from a one percent decline to a very robust eight percent growth for the first half. Not far behind was the Biomet agreed to an $11.4 billion from a private equity group.

Deal surge

According to a June 15 article in Investors' Business Daily, there have been 450 healthcare deals thus far in 2007. In the first ......

Full article >>> y that provides CEO services, including financing and business and corporate development to start-up and early-stage life science companies such as Renovar and Immune Cell Therapy. Rosen also is a founder and board member of the Illinois Biotechnology Industry Organization. He can be reached at rosenmichaels@aol.com.
......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 07/03/07


Related biology technology :

1. Midwest life science stocks sizzle in a tepid first quarter
2. A Midwest passage to India, Part II
3. Midwest offers non-stop flight to North Carolina research park
4. A Midwest life-science odyssey comes full circle
5. Midwest hotter for healthcare investments
6. A Midwest small-cap, life-science surprise package
7. 2006: A mixed blessing for Midwest life science companies
8. Midwest gaining stature in nanotech research
9. Midwest colleges strong contenders for NIH funds
10. Japan on the rebound: Implications for Midwest
11. Investor links East Coast funds to Midwest tech
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/20/2017)... ORLANDO, Fla. , Feb. 20, 2017 /PRNewswire/ ... (HIMSS) conference in Orlando , ... new offerings, collaborators and clients. IBM Chairman, President ... the HIMSS17 opening keynote address today from 8:30-10 ... www.ibm.com/watson/health , and ibm.com/industries/healthcare. Her remarks examine ...
(Date:2/18/2017)... MONTREAL , February 18, 2017 ... von intrazellulären Zytokinen bei adoptiven Zelltherapie-Studien, Poster legt metaproteomische ... ... Biosciences Inc. heute bekanntgab, wird Dr. Yoav Peretz ... Methoden in der Entwicklung von Assays zum Nachweis intrazellulärer ...
(Date:2/18/2017)... Research and Markets has announced the addition of the ... offering. ... report provides separate comprehensive analytics for the US, Japan ... Annual estimates and forecasts are provided for the period 2015 through ... Market data and analytics are derived from primary and secondary research. ...
(Date:2/17/2017)... 17, 2017  If only one in every ... mutation-conferring resistance to chemotherapy, thousands of cancer cells ... focused on finding these mutations in ever-smaller subpopulations ... tumor DNA in blood — to guide treatment ... Unfortunately, however, detecting these genetic anomalies may ...
Breaking Biology Technology:
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):